EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenolic Compounds and Pharmacological Potential of Lavandula angustifolia Extracts for the Treatment of Neurodegenerative Diseases

Olha Mykhailenko iD, Viktoriia Hurina, Nataliia Herbina, Yuliia Maslii iD, Liudas Ivanauskas, Inna Vladymyrova, Dmytro Lytkin, Zigmantas Gudžinskas iD, Hanna Severina iD, Olena Ruban, Victoriya Georgiyants iD

Plants · 20.01.2025 · 14 (2) · 289

DOI: 10.3390/plants14020289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Plants, online erschienen am 20.01.2025. Verfasst von Olha Mykhailenko und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, National University of Pharmacy, 61168 Kharkiv, Ukraine. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of Ukraine as part of the funding of a scientific topic: "Research of original substances for the correction of neurological deficits sympto…, Ministry of Health of Ukrain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The search for neuroprotective compounds in lavender is driven by its traditional use for brain health, with antioxidant activity serving as a key mechanism in reducing oxidative stress and supporting cognitive function. Lavender’s potential to protect neurons is based on its calming, anti-stress properties, which increase the brain’s resistance to neurodegeneration. Although lavender is not a traditional medicinal plant in Ukraine, it is increasingly recognised for its medicinal properties and is widely cultivated in the country. Lavender use in Ukraine is influenced by both global herbal practices and local medical traditions. The aim of this study was to optimise the preparation of lavender herb extracts, perform chemical profiling and evaluate their antioxidant and neuroprotective activities. The study focused on Lavandula angustifolia cultivated in Lviv, Ukraine. Modern analytical methods were used, including HPLC, spectrophotometry, molecular docking, lyophilisation and pharmacological testing. The selection of the optimal conditions for obtaining lavender herb extracts was determined on the basis of the results of the total yield of phenolic compounds in each extract, where it was found that the raw material–solvent ratio (1:10) in water and 50% ethanol gave the highest yield of substances; the preferred extraction time was 20 min, and the temperature was 60–70 °C, especially for water extraction. Further HPLC analysis identified marker compounds including rosmarinic acid (28.31 mg/g), chlorogenic acid (1.64 mg/g) and luteolin (0.23 mg/g) in the lyophilised ethanol extract, which were previously recognised as neuroprotective markers by molecular docking. The water extract showed higher antioxidant (total 50.85 mg/g) and neuroprotective activity, probably due to synergistic interactions among the components. Behavioural tests further demonstrated the neuroprotective potential of lavender herb. These results demonstrate the potential neuroprotective activity of lavender herb and open new possibilities for its use in the treatment of various neurodegenerative diseases.

Schlagwörter

Stichwörter der Autor:innen

Lavandula angustifoliaantioxidant activityethnopharmacologyextractionlyophilised extractsneurotropic activityphenolic compounds

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, National University of Pharmacy, 61168 Kharkiv, Ukraine.
  • Department of Pharmaceutical and Biological Chemistry, Pharmacognosy and Phytotherapy Group, UCL School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UK.
  • Department of Pharmaceutical Biology, Kiel University, 24118 Kiel, Germany.
  • Department of Drug Technology and Social Pharmacy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
  • Department of Analytical and Toxicological Chemistry, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
  • Department of Clinical Pharmacology, Institute for Advanced Training of Pharmacy Specialists, National University of Pharmacy, 61001 Kharkiv, Ukraine.

ORCID-Profile: Olha Mykhailenko, Yuliia Maslii, Zigmantas Gudžinskas, Hanna Severina, Victoriya Georgiyants

Förderung

  • Ministry of Health of Ukraine as part of the funding of a scientific topic: "Research of original substances for the correction of neurological deficits sympto…
  • Ministry of Health of Ukrain

Zitieren

APA

Mykhailenko, O., Hurina, V., Herbina, N., Maslii, Y., Ivanauskas, L., Vladymyrova, I., Lytkin, D., Gudžinskas, Z., Severina, H., Ruban, O., & Georgiyants, V. (2025). Phenolic Compounds and Pharmacological Potential of Lavandula angustifolia Extracts for the Treatment of Neurodegenerative Diseases. Plants, 14(2), 289. https://doi.org/10.3390/plants14020289

Vancouver

Mykhailenko O, Hurina V, Herbina N, Maslii Y, Ivanauskas L, Vladymyrova I, et al. Phenolic Compounds and Pharmacological Potential of Lavandula angustifolia Extracts for the Treatment of Neurodegenerative Diseases. Plants. 2025;14(2):289. doi:10.3390/plants14020289

BibTeX
@article{Mykhailenko2025,
  author = {Mykhailenko, Olha and Hurina, Viktoriia and Herbina, Nataliia and Maslii, Yuliia and Ivanauskas, Liudas and Vladymyrova, Inna and Lytkin, Dmytro and Gudžinskas, Zigmantas and Severina, Hanna and Ruban, Olena and Georgiyants, Victoriya},
  title = {Phenolic Compounds and Pharmacological Potential of Lavandula angustifolia Extracts for the Treatment of Neurodegenerative Diseases},
  journal = {Plants},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {289},
  doi = {10.3390/plants14020289}
}
Kostenlos starten →